Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2015 · 10-Q
Revenue$65.94M$65.94M−4.5% vs Q3 2014 Net Income$5.51M$5.51M+13.4% vs Q3 2014 EPS Diluted$0.46$0.46+17.9% vs Q3 2014 Gross Profit$49,160,000−3.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$9,459,000+14.5% Free Cash Flowderived$9,227,000+30.4% Margins · derivedGross margin74.6%+1.0 pt vs Q3 2014
Operating margin12.1%+2.5 pt vs Q3 2014
Net margin8.4%+1.3 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 9, 2015 · 40 d after period end